A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Psoriasis, Plaque Psoriasis

In brief

This Phase 2 study has been designed to investigate the clinical safety and efficacy of EDP1815 and to identify an optimal dose in subjects with mild to moderate psoriasis.

Key facts

Study ID
NCT04603027
Run by
Evelo Biosciences, Inc.
People needed
249
Starts
2020-09-21
Expected to finish
2021-12-06
Last updated by the study team
2022-12-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.